Background Heterogeneity is a major obstacle to developing effective treatments for patients
with primary Sjögren's syndrome. We aimed to develop a robust method for stratification …

Objective We propose new classification criteria for Sjögren's syndrome (SS), which are
needed considering the emergence of biologic agents as potential treatments and their …

Objective Although symptom relief is a critical aspect for successful drug development in
Sjögren's disease, patient experiences with Sjögren'srelated symptoms are understudied …

Lymphocytic infiltration of different exocrine and non-exocrine epithelia is the pathological
hallmark of primary Sjögren's syndrome, whereas involvement of salivary and lachrymal …

Objectives To develop and validate an international set of classification criteria for primary
Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology …

Objective To develop and validate an international set of classification criteria for primary
Sjögren's Syndrome (pSS) using guidelines from the American College of Rheumatology …

There is currently no approved treatment for primary Sjögren's syndrome, a disease that
primarily affects adult women. The difficulty in developing effective therapies is-in part …

Background Recent randomised controlled trials (RCTs) in primary Sjögren's syndrome
used the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease …

Objective To develop a composite responder index in primary Sjögren's syndrome (pSS):
the Sjögren's Tool for Assessing Response (STAR). Methods To develop STAR, the …

Objective To characterize the systemic phenotype of primary Sjögren's syndrome at
diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores. Methods The …